
1. antimicrob agents chemother. 2020 jun 23;64(7). pii: e02125-19. doi:
10.1128/aac.02125-19. print 2020 jun 23.

influence cyp2c8, cyp3a4, cyp3a5 host genotypes early recurrence of
plasmodium vivax.

almeida acg(1)(2), puça mcb(1), figueiredo efg(1)(2), barbosa lr(1)(2), salazar
year(1), silva el(1), brito mam(1)(2), siqueira am(3), vieira jlf(4), lacerda
mvg(1)(2)(5), monteiro wm(1)(2), melo gc(6)(2).

author information: 
(1)instituto de pesquisa clínica carlos borborema, fundação de medicina tropical 
dr. heitor vieira dourado, manaus, amazonas, brazil.
(2)programa de pós-graduação em medicina tropical, universidade estado do
amazonas, manaus, amazonas, brazil.
(3)fundação oswaldo cruz, instituto de pesquisa clínica evandro chagas, instituto
nacional de infectologia evandro chagas-fiocruz, rio de janeiro, rio de janeiro, 
brazil.
(4)universidade federal pará, belem, brazil.
(5)instituto leônidas & maria deane, fundação oswaldo cruz, manaus, amazonas,
brazil.
(6)instituto de pesquisa clínica carlos borborema, fundação de medicina tropical 
dr. heitor vieira dourado, manaus, amazonas, brazil cardosogisely@gmail.com.

cytochrome p450 (cyp) enzymes involved biotransformation of
chloroquine (cq), role different profiles metabolism this
drug relation plasmodium vivax recurrences properly
investigated. investigate influence cyp genotypes associated with
cq metabolism rates p. vivax early recurrences, case-control study
was carried out. cases included patients presenting early recurrence 
(cq-recurrent individuals), defined recurrence first 28 days
after initial infection plasma concentrations cq plus desethylchloroquine 
(dcq; major cq metabolite) higher 100 ng/ml. control group no
parasite recurrence follow-up (the cq-responsive group) also
included. cq dcq plasma levels measured day 28. cq-metabolizing cyp
(cyp2c8, cyp3a4, cyp3a5) genotypes determined real-time pcr. ex
vivo study conducted verify efficacy cq dcq p. vivax
isolates. frequency alleles associated normal slow metabolism was
similar cases controls cyp2c8 (odds ratio
[or] = 1.45, 95% confidence interval [ci] = 0.51 4.14, p = 0.570), cyp3a4
(or = 2.38, 95% ci = 0.92 6.19, p = 0.105), cyp3a5 (or = 4.17, 95%
ci = 0.79 22.04, p = 1.038) genes. dcq levels higher cq levels,
regardless genotype. regarding dcq/cq ratio, difference
between groups patients normal genotype those
patients mutant genotype. dcq cq showed similar efficacy ex vivo
cyp genotypes influence early recurrence rates. similar efficacy of
cq dcq ex vivo could explain absence therapeutic failure, despite 
presence alleles associated slow metabolism.

copyright © 2020 american society microbiology.

doi: 10.1128/aac.02125-19 
pmcid: pmc7317997 [available 2020-12-23]
pmid: 32366712 

